UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: DZPorifarm-10mg-Solution-SE-IS-RA

Generated Narrative: RegulatedAuthorization DZPorifarm-10mg-Solution-SE-IS-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/57370

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100002342-00057370,http://ema.europa.eu/fhir/eurdId#1029; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Diazepam påverkar de vid ångestsyndrom vanliga symtomen ängslan, ångest, rastlöshet och därav följande sömnsvårigheter. Vid depressioner med inslag av nämnda symtom kan Diazepam Orifarm ges i kombination med antidepressiva farmaka. Delirium tremens, predeliriösa tillstånd och akuta abstinenssymtom i samband med alkoholmissbruk. Cerebralt och perifert betingade muskelspasmer. Premedicinering.; legalStatusOfSupply = Medicinal product subject to special medical prescription; classification = N05BA01

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2018-10-12

holder: Organization Orifarm Generics A/S

Cases

-TypeDate[x]
*First Authorisation2018-10-12